Display options
Cite
Rhiem K, Schmutzler R. Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers. Breast Care (Basel). 2014;9(6):385-9doi: 10.1159/000369592.
Rhiem, K., & Schmutzler, R. (2014). Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers. Breast care (Basel, Switzerland), 9(6), 385-9. https://doi.org/10.1159/000369592
Rhiem, Kerstin, and Schmutzler, Rita. "Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers." Breast care (Basel, Switzerland) vol. 9,6 (2014): 385-9. doi: https://doi.org/10.1159/000369592
Rhiem K, Schmutzler R. Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers. Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592. PMID: 25759620; PMCID: PMC4317675.
Copy Download .nbib Format: NLM
Share it on

Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592.

Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.

Breast care (Basel, Switzerland)

Kerstin Rhiem, Rita Schmutzler

Affiliations

  1. Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Germany.

PMID: 25759620 PMCID: PMC4317675 DOI: 10.1159/000369592

Abstract

Unlike the general decrease in invasive oncologic care, the trend for prophylactic bilateral mastectomy in healthy women and prophylactic contralateral mastectomy in women with unilateral breast cancer is steadily rising. This is even more surprising when considering that for e.g. prophylactic contralateral mastectomy no clear survival benefit has been demonstrated so far. The decision-making process around risk-reducing surgery may be influenced by several conflicting parameters such as the patient's fears and desire to achieve a survival advantage, the surgeon's financial motivations, or the oncologist's paternalistic approach to the above trend. Physicians should support their patients throughout the decision-making process, guide them through the dense fog of information, and encourage them to reconsider all options and alternatives before embarking on an irreversible surgical intervention. Healthy and diseased women should be comprehensively informed about their absolute individual risks for cancer, the benefits and harms of the surgery, alternative preventive strategies, and last but not least the competing risks of preceding carcinomas and cancer in general. Within the framework of non-directive counseling in the specialized centers of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC), decision-making aids are being developed with grants from the Federal Ministry of Health and the German Cancer Aid to support women in making conclusive and satisfactory decisions.

Keywords: BRCA1; BRCA2; High-risk genes; Prophylactic mastectomy

References

  1. N Engl J Med. 2002 May 23;346(21):1609-15 - PubMed
  2. J Natl Cancer Inst. 2013 Jun 5;105(11):812-22 - PubMed
  3. JAMA. 2010 Sep 1;304(9):967-75 - PubMed
  4. J Clin Oncol. 2011 Jun 1;29(16):2158-64 - PubMed
  5. Breast Cancer Res. 2012 Dec 07;14(6):R156 - PubMed
  6. N Engl J Med. 2001 Jul 19;345(3):159-64 - PubMed
  7. J Clin Oncol. 2007 Nov 20;25(33):5203-9 - PubMed
  8. Gynecol Oncol. 2006 Dec;103(3):1077-82 - PubMed
  9. Genet Med. 2014 Jul;16(7):516-21 - PubMed
  10. Lancet. 2010 Jul 24;376(9737):235-44 - PubMed
  11. Br J Cancer. 2005 Aug 8;93(3):287-92 - PubMed
  12. J Gen Intern Med. 1996 Feb;11(2):92-7 - PubMed
  13. Clin Cancer Res. 2005 Jul 15;11(14):5175-80 - PubMed
  14. BMJ. 2014 Feb 11;348:g226 - PubMed
  15. J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45 - PubMed
  16. Genes Chromosomes Cancer. 2010 Dec;49(12):1082-94 - PubMed
  17. J Clin Oncol. 2009 Dec 10;27(35):5887-92 - PubMed
  18. N Engl J Med. 2002 May 23;346(21):1616-22 - PubMed
  19. J Clin Oncol. 2004 Mar 15;22(6):1055-62 - PubMed
  20. Dtsch Arztebl Int. 2011 May;108(19):323-30 - PubMed
  21. Breast Cancer Res Treat. 2009 Sep;117(1):183-91 - PubMed
  22. Breast Cancer Res Treat. 2010 Apr;120(3):715-23 - PubMed
  23. Lancet. 2010 Jul 24;376(9737):245-51 - PubMed
  24. Clin Cancer Res. 2000 Mar;6(3):782-9 - PubMed
  25. Breast Cancer Res. 2004;6(1):R8-R17 - PubMed
  26. Breast Cancer Res Treat. 2003 Feb;77(3):285-93 - PubMed

Publication Types